J. Turkson
Oncogene · 2000–2007
A researcher in the Science corpus: 6 papers; trusts 0 researchers and is trusted by 4 researchers here, as inferred from the citation graph.
Whom J. Turkson trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts J. Turkson overall
Papers from J. Turkson's perspective
Ordered by how strongly the researchers J. Turkson trusts endorse each paper. Same corpus, a different order for every researcher.
- The role of STATs in transcriptional control and their impact on cellular function (Oncogene)
- STATs in oncogenesis (Oncogene)
- Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors (Oncogene)
- Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma. (Blood)
- Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin. (Journal of Clinical Oncology)
- Serine phosphorylation of STATs (Oncogene)
- Drug discovery: a historical perspective. (Science)
- Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo. (Proceedings of the National Academy of Sciences of the United States of America)
- Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression. (Journal of Clinical Investigation)
- Muscle‐derived interleukin‐6: possible biological effects (Journal of Physiology)
Their papers
- Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis (2002) — 1,244 citations
- STAT proteins: novel molecular targets for cancer drug discovery (2000) — 678 citations
- STATs in oncogenesis (2000) — 1,862 citations
- Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity (2007) — 754 citations
- Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice. (2003) — 620 citations
- Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression. (2001) — 661 citations